Vera Health Raises $28.5M to Scale Clinical AI Search
Vera Health raised $28.5M Series A led by Threshold Ventures to scale its AI search engine for medical evidence, used by 800,000 clinicians.
The big picture: Vera Health, a clinical AI search platform, today announced a $28.5 million Series A funding round. The investment was led by Threshold Ventures, with participation from Optum Ventures, Mantis VC, and SV Angel. Existing investors Y Combinator and Gradient also increased their backing, bringing the company’s total funding to $32 million.
Why it matters:
- Information Overload: Physicians face an overwhelming volume of new medical research, with a new paper published every 20 seconds, making it difficult to stay current and find relevant evidence for patient care.
- Evidence-Based Practice: Vera Health helps clinicians quickly access and evaluate medical evidence from over 60 million sources, improving the speed and quality of clinical decision-making by clearly presenting sources, strength, and limitations.
- Global Reach & Localization: The platform is used by over 800,000 clinicians in 190 countries, offering localized guidance and supporting health equity by making knowledge accessible regardless of practice location.
How it works:
- AI-Powered Search & Evaluation: Vera Health’s clinical AI search engine reasons like a clinician, searching scientific publications, clinical guidelines, and drug labels to evaluate evidence before generating answers.
- Transparent Evidence Ranking: Every claim is linked to supporting research and color-coded to indicate evidence strength, allowing physicians to assess reliability and limitations, even for rare conditions with limited data. The system highlights disagreements when studies or guidelines conflict.
- Customizable & Localized Guidance: The platform accounts for national and regional clinical guidelines, reads local-language sources, and allows health systems to integrate their own protocols and pathways via Vera Spaces.
The catch: The market for clinical decision support and medical AI tools is increasingly competitive, with established players and new startups vying for clinician adoption. While Vera Health boasts significant user numbers, maintaining growth and fending off competitors will require continuous innovation and strong partnerships. The company’s free-for-doctors, paid-by-hospitals model relies on bottom-up adoption, which can be slower than top-down sales cycles, potentially impacting revenue growth despite user engagement. Furthermore, the critical need for accuracy and trust in medical AI means any perceived error or bias could severely undermine clinician confidence and adoption, particularly given the platform’s emphasis on transparency and evidence ranking.
Key Facts
- Company: Vera Health
- Amount: $28.5M
- Round: Series A
- Investors: Threshold Ventures (lead), Optum Ventures, Mantis VC, SV Angel, Y Combinator, Gradient
- Founders: Maxime Allouch, Taieb Bennani
- Announced: 2026-10-27
- Sector: Medical Evidence AI
AIPressRoom Weekly
Every round we reported this week, the people behind the companies, and the events coming up. One email, every Tuesday.